-
Investment type
-
Equity - Shares of Stock
-
Class
-
Common Stock, par value $0.0001 per share
-
Latest Disclosed Ownership
-
1.75M shares
-
Security Ownership
-
5.2%
Novo Holdings A/S ownership in ArriVent BioPharma, Inc. Common Stock, par value $0.0001 per share
2025-02-14 - Novo Holdings A/S has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.75M shares of ArriVent BioPharma, Inc. Common Stock, par value $0.0001 per share.
This represents 5.2% percent ownership of the company.